Viewing nowCombinationNobartan Tablet 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.

MFDS item code 201308590 · Approved 2013.07.31 · Insurance code 665001760
Treatment of essential hypertension not controlled with monotherapy
For patients with essential hypertension, if blood pressure control is insufficient with monotherapy of amlodipine or valsartan, effective management of blood pressure can be achieved through combination therapy. This helps lower blood pressure, reduces cardiovascular risks, and prevents complications. This treatment is used to safely and steadily control blood pressure to maintain healthy vascular conditions.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Administration of this drug is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.
This medication may cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so discontinue use immediately upon confirmation of pregnancy. This medicine should not be administered to individuals who are allergic to active ingredients or similar components, to women who are pregnant or breastfeeding, to patients with severe kidney or liver disease, or to patients with a history of specific heart diseases or vascular edema. Patients with low sodium or body fluid levels may face hypotension risks, so their condition should be checked before administration, and blood pressure and condition should be closely monitored during use. Patients with high potassium levels or those taking medications that may increase potassium levels should have their potassium levels frequently monitored, and patients with impaired renal function should also exercise caution. Since this medication may have a strong blood pressure-lowering effect, if hypotensive symptoms appear, the patient should be placed flat, and if necessary, isotonic saline should be administered to stabilize blood pressure. Patients with heart conditions such as heart failure or post-myocardial infarction, as well as those with acute myocardial infarction, should have their kidney function and condition carefully monitored while taking this medication. This drug may cause dizziness or fatigue during driving or operating machinery; caution is advised. The usual dosage is recommended for the elderly, but greater caution is required for patients with decreased kidney or liver function. This medication may interact with other antihypertensives, diuretics, potassium-sparing agents, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so be sure to inform healthcare providers of any medications being taken. In case of overdose, symptoms such as hypotension, dizziness, and irregular heartbeat may occur, so it is essential to visit a medical facility immediately for appropriate treatment. It is not recommended for pediatric patients as safety and efficacy have not been adequately established. If unusual symptoms occur during the course of treatment with this medication, it is important to consult with a healthcare provider for appropriate measures.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, increased frequency of urination, polyuria, erectile dysfunction, edema, localized edema, facial swelling, peripheral edema, fatigue, flushing, asthenia, facial flushing, reduced hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vessel edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorder, peripheral neuropathy, hypermuscle tension, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurosensitization, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival polymorphism, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to store the drug at a normal room temperature between 1 to 30 degrees Celsius, avoiding extremely hot or cold places.
Dark yellow egg-shaped film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.